SHUTTLE PHARMACEUTICALS HOLDINGS, INC. Business Combination, Contingent Consideration, Liability, Current
SHUTTLE PHARMACEUTICALS HOLDINGS, INC. (SHPH) had Business Combination, Contingent Consideration, Liability, Current of $250.00 thousand as of 2026-06-30, per its 10-Q filed 2026-09-24.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent · last filed 2026-09-24
- 2026-06-30: Business Combination, Contingent Consideration, Liability, Current $250.00K.
- 2026-03-31: Business Combination, Contingent Consideration, Liability, Current $4.44M.
- 2025-12-31: Business Combination, Contingent Consideration, Liability, Current $2.00M; Business Combination, Contingent Consideration, Liability, Current as first filed $4.44M.
| Period end | Business Combination, Contingent Consideration, Liability, Current | Business Combination, Contingent Consideration, Liability, Current as first filed |
|---|---|---|
| 2026-06-30 | $250.00K 10-Q · filed 2026-09-24 | |
| 2026-03-31 | $4.44M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $2.00M 10-Q · filed 2026-09-24 | $4.44M 10-K · filed 2026-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |